---
document_datetime: 2023-09-21 20:10:47
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/zerit-epar-all-authorised-presentations_en.pdf
document_name: zerit-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.3553261
conversion_datetime: 2025-12-31 05:24:50.267649
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
EU number

EU/1/96/009/001

EU/1/96/009/002

EU/1/96/009/003

EU/1/96/009/004

EU/1/96/009/005

EU/1/96/009/006

EU/1/96/009/007

EU/1/96/009/008

EU/1/96/009/009

Invented name

Zerit

Zerit

Zerit

Zerit

Zerit

Zerit

Zerit

Zerit

Zerit

Strength

15 mg

15 mg

20 mg

20 mg

30 mg

30 mg

40 mg

40 mg

200 mg

Pharmaceutical form

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Powder for oral solution

Route of administration  Packaging

Oral use

Bottle (HDPE)

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

1/1

Blister (aclar/alu)

Bottle (HDPE)

Blister (aclar/alu)

Bottle (HDPE)

Blister (aclar/alu)

Bottle (HDPE)

Blister (aclar/alu)

Bottle (HDPE)

<!-- image -->

Content

(concentration)

200 mg (1 mg/ml)

after reconstitution

Package size

60 capsules

56 capsules

60 capsules

56 capsules

60 capsules

56 capsules

60 capsules

56 capsules

1 Bottle

ï£© EMEA 2006 Medicinal product no longer authorised